Louisiana Wholesale Drug Co. v. Bayer AG

Petition for certiorari denied on March 7, 2011

Docket No.	Op. Below	Argument	Opinion	Vote	Author	Term
10-762	2d Cir.	N/A	N/A	N/A	N/A	OT 2010

Issue: Whether, absent patent fraud or sham litigation, a brand drug maker's substantial payment to a competing generic drug maker to forgo judicial testing of the patent and restrict entry is per se lawful under the Sherman Act.

Briefs and Documents

Opinion below (2d Cir.)
Petition for certiorari
Brief in opposition of Barr Laboratories et al.
Brief in opposition of Bayer AG et al.
Petitioners' reply
Amicus brief of the American Antitrust Institute
Amicus brief of California et al.
Amicus brief of 86 Professors
Amicus brief of the Consumer Federation of America et al.
Amicus brief of AARP
Amicus brief of the Public Patent Foundation
Amicus brief of the National Association of Chain Drug Stores, Inc.

Breaking News

Louisiana Wholesale Drug Co. v. Bayer AG

Briefs and Documents

Certiorari-stage documents

Supreme Court appears ready to uphold Tennessee ban on youth transgender care

Justices weigh Holocaust survivors’ right to sue Hungary for compensation

Federal trademark law and doctrines of corporate identity

Court turns down challenges to school admissions, gender support plans, and gun licensing